Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: A pilot study

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Gray, Clint ^a   McCowan, Lesley M ^b   Patel, Rachna ^a   Taylor, Rennae S ^b   Vickers, Mark H ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; MULTICENTER STUDY; PILOT STUDY; PREGNANCY; PREMATURITY;

ADULT; BIOMARKERS; FEMALE; HUMANS; MICRORNAS; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTERS; PREMATURE BIRTH;

EID: 85018784331     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00713-8     Document Type: Article

References (36)

1. Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388(10063), 3027-3035 (2017).
2. Lawn, J. E., Kerber, K., Enweronu-Laryea, C. & Cousens, S. 3.6 million neonatal deaths-what is progressing and what is not? Semin Perinatol 34, 371-386 (2010).
3. Lawn, J. E., Cousens, S. & Zupan, J. 4 million neonatal deaths: when? Where? Why? Lancet 365, 891-900 (2005).
4. Organisation, W. H. Born Too Soon: The Global Action Report on Preterm Birth. Report No. 2012, (2012).
5. Lucovnik, M. et al. Changes in incidence of iatrogenic and spontaneous preterm births over time: a population-based study. J Perinat Med 44, 505-509 (2016).
6. Slattery, M. M. & Morrison, J. J. Preterm delivery. Lancet 360, 1489-1497 (2002).
7. Chen, K. & Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8, 93-103 (2007).
8. Ameres, S. L. & Zamore, P. D. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 14, 475-488 (2013).
9. Nguyen, M. A., Karunakaran, D. & Rayner, K. J. Unlocking the Door to New Therapies in Cardiovascular Disease: MicroRNAs Hold the Key. Current Cardiology Reports 16, 539 (2014).
10. Li, H., Wang, Z., Fu, Q. & Zhang, J. Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 19, 553-556 (2014).
11. Ayaz, L. et al. Circulating microRNA expression profiles in ovarian cancer. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology 34, 620-624 (2014).
12. Guo, L. et al. Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas. Placenta 34, 599-605 (2013).
13. Li, H., Ge, Q., Guo, L. & Lu, Z. Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int 2013, 970265 (2013).
14. Xu, P. et al. Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension 63, 1276-1284 (2014).
15. Hong, F., Li, Y. & Xu, Y. Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with preeclampsia. The Journal of International Medical Research 42, 1243-1251 (2014).
16. Wang, Y. et al. miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe preeclampsia. The FEBS Journal 279, 4510-4524 (2012).
17. Zhao, G. et al. Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia. J Biomed Sci 21, 81 (2014).
18. Elovitz, M. A. et al. Distinct cervical microRNA profiles are present in women destined to have a preterm birth. Am J Obstet Gynecol 210(221), e221-211 (2014).
19. Sanders, A. P. et al. microRNA expression in the cervix during pregnancy is associated with length of gestation. Epigenetics 10, 221-228 (2015).
20. Renthal, N. E. et al. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 107, 20828-20833 (2010).
21. Williams, K. C., Renthal, N. E., Condon, J. C., Gerard, R. D. & Mendelson, C. R. MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc Natl Acad Sci USA 109, 7529-7534 (2012).
22. Williams, K. C., Renthal, N. E., Gerard, R. D. & Mendelson, C. R. The microRNA (miR)-199a/214 cluster mediates opposing effects of progesterone and estrogen on uterine contractility during pregnancy and labor. Mol Endocrinol 26, 1857-1867 (2012).
23. Elovitz, M. A., Anton, L., Bastek, J. & Brown, A. G. Can microRNA profiling in maternal blood identify women at risk for preterm birth? Am J Obstet Gynecol 212(782), e781-785 (2015).
24. Tam, S., de Borja, R., Tsao, M. S. & McPherson, J. D. Robust global microRNA expression profiling using next-generation sequencing technologies. Laboratory investigation; a journal of technical methods and pathology 94, 350-358 (2014).
25. Martin, J. W. et al. Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma. PLoS One 9, e95843 (2014).
26. Chim, S. S. et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54, 482-490 (2008).
27. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 18, 997-1006 (2008).
28. Lindner, K. et al. Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers. Clin Sci (Lond) 128, 1-15 (2015).
29. Xie, W. Q., Zhou, L., Chen, Y. & Ni, B. Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects. World Journal of Emergency Medicine 7, 85-89 (2016).
30. Hassan, S. S. et al. MicroRNA expression profiling of the human uterine cervix after term labor and delivery. Am J Obstet Gynecol 202(80), e81-88 (2010).
31. Shi, Y., Qiu, M., Wu, Y. & Hai, L. MiR-548-3p functions as an anti-oncogenic regulator in breast cancer. Biomed Pharmacother 75, 111-116 (2015).
32. Li, Y. et al. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-lambda1. Protein & cell 4, 130-141 (2013).
33. Tsochandaridis, M., Nasca, L., Toga, C. & Levy-Mozziconacci, A. Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications. Biomed Res Int 2015, 294954 (2015).
34. Mouillet, J. F. et al. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31, 781-784 (2010).
35. McCowan, L. M. et al. Clinical prediction in early pregnancy of infants small for gestational age by customised birthweight centiles: findings from a healthy nulliparous cohort. PLoS One 8, e70917 (2013).
36. McCowan, L. M. et al. Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG 117, 1599-1607 (2010).